Addressing the burden of dialysis around the world: <scp>A</scp> summary of the roundtable discussion on dialysis economics at the <scp>F</scp>irst <scp>I</scp>nternational <scp>C</scp>ongress of <scp>C</scp>hinese <scp>N</scp>ephrologists 2015

Li, Philip Kam-Tao; Lui, Sing Leung; Ng, Jack Kit-Chung; Cai, Guan Yan; Chan, Christopher T.; Chen, Hung Chun; Cheung, Alfred K.; Choi, Koon Shing; Choong, Hui Lin; Fan, Stanley; Ong, Loke Meng; Yu, Linda; Yu, Xue

doi:10.1111/nep.13143

Cited by 12 publications

(9 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The Chinese National Renal Data System (CNRDS) is initiated by the Chinese Society of Nephrology under the lead of the Ministry of Health of China in 2010. The main objectives of the CNRDS include collection of demographic, clinical and laboratory data of HD and peritoneal dialysis (PD) cases to establish a kidney disease database for research and policy making [2]. The data for retrospective analysis were exported from the CNRDS, including new, long-term and dead ESRD-HD patients from 01 January 2011 to 31 December 2016 in south west of China, Sichuan province.…”

Section: Clinical Materials and Methodologymentioning

confidence: 99%

“…The choice of predominant method of RRT varies in different countries. In China, about 86% of the dialysis population receive hemodialysis (HD) [2], and about 72.8%, 84% of the dialysis population receive HD in Zhejiang province, Shanghai of China, respectively [2,3]. HD is still considered as a major treatment choice for patients in Sichuan province in southwest of China, and receive HD twice or thrice weekly.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Epidemiology investigation and analysis of patients with hemodialysis in Sichuan province of China

Zou

Hong

et al. 2019

Renal Failure

View full text Add to dashboard Cite

Objectives: To investigate the incidence, pathogenesis, as well as mortality rate and causes of end-stage renal disease patients with hemodialysis (ESRD-HD) in Sichuan province of China. Methods: In this retrospective descriptive study, all the data were exported from the Chinese National Renal Data System (CNRDS). The demographic and pathogenic information from 01 January 2011 to 31 December 2016 were statistically analyzed. Results: According to the data from CNRDS, the incidence of ESRD-HD was high in Sichuan province. From 2011 to 2016, the annual incidence rate of ESRD-HD was 61.84, 73.75, 78.04, 66.04, 72.61, and 60.98 per million population (pmp). Male ESRD-HD patients were higher than female patients (1.5:1). The major causes of ESRD-HD in Sichuan province from 2011 to 2016 were chronic glomerulonephritis and diabetic nephropathy. The annual mortality rate of ESRD-HD was 113.20, 91.25, 73.02, 68.56, 68.57, and 58.39 per 1000 person-years. The descending rate of mortality was parallel in both males and females. The mortality rate was observed to be higher in the elderly group (age ≥ 60). The major cause of mortality was cardiovascular diseases (24.48%). Conclusions: In Sichuan province, the incidence of ESRD-HD annually was gradually descending. The elderly and male patients had higher incidence of ESRD-HD. The annual mortality rate of ESRD-HD was declining year by year, and elderly patients aged ≥ 60 contributed to the highest mortality rates. The major cause of death was cardiovascular diseases. This could contribute to a better understanding of ESRD-HD in southwest of China, thus providing better treatment for ESRD in the future.

show abstract

Section: Clinical Materials and Methodologymentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Epidemiology investigation and analysis of patients with hemodialysis in Sichuan province of China

Zou

Hong

et al. 2019

Renal Failure

View full text Add to dashboard Cite

show abstract

“…We believed that was because Taiwan has the highest prevalence of end-stage kidney disease (ESKD) in the world and the incidence of AF is notably high in patients requiring hemodialysis. 17 Regarding the echocardiographic ndings, there were no signi cant differences in left atrium size and left ventricular systolic function between the two cohorts. The proportion of paroxysmal AF was signi cantly higher in cohort 1 compared to cohort 2 (68.6% vs. 41.9%, P=0.008).…”

Section: Study Population and Clinical Characteristicsmentioning

confidence: 82%

Changes of antithrombotic prescription in atrial fibrillation patients with acute coronary syndrome or percutaneous coronary intervention and the subsequent impact on long-term outcomes: A longitudinal cohort study

Lee¹,

Chang²,

Hung³

et al. 2021

Preprint

View full text Add to dashboard Cite

Objectives:The choice of optimal antithrombotic therapy in atrial fibrillation (AF) patients with acute coronary syndrome (ACS) or percutaneous coronary intervention (PCI) remains controversial. The aim of this longitudinal cohort study is to investigate the prescribing pattern of antithrombotic regimen in different cohorts and its subsequent impact. Setting and Design:Longitudinal data from the Tri-Service General Hospital-Coronary Heart Disease (TSGH-CHD) registry, between January 2016 and August 2018 was screened. Participants and method:Patients with prior history of nonvalvular AF, who had ACS presentation or had underwent PCI were selected, and these patients were divided into cohort 1 and cohort 2, according to the index date of antithrombotic prescription before and after the PIONEER AF-PCI study.Primary and secondary outcomes:The primary safety endpoints were composites of major bleeding and/or clinically relevant non-major bleeding. The secondary efficacy endpoints included the occurrence of all-cause mortality, stroke/systemic embolization, nonfatal myocardial infarction (MI), and >30-days coronary revascularization. Results:A total of 121 patients were included into analysis (cohort 1=35; cohort 2=86). Comparing with cohort 1, the prescription rate of triple antithrombotic therapy (TAT) increased from 17.1% to 38.4%, especially the regimen with dual antiplatelet therapy (DAPT) plus low-dose non-vitamin-K dependent oral anticoagulation (NOAC). However, the prescription rate of dual antithrombotic therapy (DAT) decreased (14.3% to 10.5%), as well as the prescription rate of DAPT (68.6% to 51.2%). These changes of antithrombotic prescription across different cohorts were not associated with risk of adverse safety (HR= 0.87; 95% CI, 0.42-1.80, p=0.710) and efficacy outcomes (HR=0.96; 95% CI, 0.40-2.32, p=0.930). Conclusions: Entering the NOAC era, the prescription of TAT increased alongside the decrease in DAT. As the prescription rate of DAPT without anticoagulation remained high, future efforts are mandatory to improve the implementation of guidelines and clinical practice.

show abstract

“…With changes in the disease spectrum in China, there has been an increase in the incidence of chronic diseases, including the number of patients with end‐stage renal disease (ESRD). According to the Chinese National Renal Data System, the number of patients with renal replacement therapy in China had increased from 100,000 in 2000 to nearly 400,000 in 2014 (Li et al, 2017). Maintenance haemodialysis (MHD) is currently the main treatment modality for ESRD in China.…”

Section: Introductionmentioning

confidence: 99%

Exploring psychosocial factors associated with frailty incidence among patients undergoing maintenance hemodialysis

Yuan

Zhang

Xue

et al. 2020

Journal of Clinical Nursing

View full text Add to dashboard Cite

Aim and objective:We investigated the correlation between the frailty status of maintenance haemodialysis (MHD) patients and psychosocial factors.Background: Varying degrees of frailty have been reported in MHD patients, which affect their quality of life.Design: We adopted a cross-sectional design in this study. Methods: Clinical data of 187 patients at our centre were collected from December 2017-June 2018 using a cross-sectional survey. Psychosocial factors were measured using the Pittsburgh Sleep Quality Index (PSQI), Hospital Anxiety and Depression Scale, 10-item Connor-Davidson Resilience Scale (CD-RISC), Chronic Disease Self-Efficacy Scales and Perceived Social Support Scale. Frailty status was estimated using the fatigue, resistance, ambulation, illnesses and loss of weight (FRAIL) scale.Spearman's correlation and multiple logistic regression analysis were conducted to identify the risk factors for frailty. This study complied with the STROBE checklist.Results: Of 187 patients, 11 cases (5.9%) of frailty were identified. Patient's age, comorbidities, parathyroid hormone level, sleep quality and depression were positively correlated with frailty (p < .05), while psychological resilience and social support were negatively correlated with frailty (p < .05). Logistic regression analysis revealed four risk factors for frailty among MHD patients, including age (p = .004), comorbidities (p = .023), depression (p = .023) and sleep disorders (p = .029). Conversely, protective factors included high psychological resilience (p = .019) and social support (p = .039). Conclusion:Among MHD patients, the risk factors for frailty included age, comorbidity, depression and sleep disturbance, whereas the protective factors included psychological resilience and social support. Relevance to clinical practice:Frailty is not only common among older patients, but also among people of all age groups suffering from chronic diseases. Therefore, it is important to consider the health status of MHD patients and adopt targeted nursing strategies to alleviate symptoms of frailty and improve physical condition by the following ways: postpone the progress of comorbidities, improve sleep quality, control S U PP O RTI N G I N FO R M ATI O N Additional supporting information may be found online in the Supporting Information section. P. Exploring psychosocial factors associated with frailty incidence among patients undergoing maintenance hemodialysis.

show abstract

Addressing the burden of dialysis around the world: A summary of the roundtable discussion on dialysis economics at the First International Congress of Chinese Nephrologists 2015

Cited by 12 publications

References 13 publications

Epidemiology investigation and analysis of patients with hemodialysis in Sichuan province of China

Epidemiology investigation and analysis of patients with hemodialysis in Sichuan province of China

Changes of antithrombotic prescription in atrial fibrillation patients with acute coronary syndrome or percutaneous coronary intervention and the subsequent impact on long-term outcomes: A longitudinal cohort study

Exploring psychosocial factors associated with frailty incidence among patients undergoing maintenance hemodialysis

Contact Info

Product

Resources

About